Literature DB >> 20807976

Chronic kidney disease and postoperative morbidity after elective orthopedic surgery.

Gareth L Ackland1, Noeleen Moran, Steven Cone, Michael P W Grocott, Michael G Mythen.   

Abstract

BACKGROUND: Reduced estimated glomerular filtration rate (eGFR) is strongly associated with increased cardiovascular risk and all-cause mortality. Associations with morbidity in elective, moderate-risk noncardiac surgery have not been explored. We hypothesized that chronic kidney disease (CKD) would be associated with excess morbidity after elective, moderate-risk orthopedic surgery.
METHODS: Patients undergoing elective orthopedic joint replacement procedures were studied, representing a large proportion of global surgical procedures and characterized by highly homogeneous anesthetic and surgical practice. eGFR was calculated from routine creatinine measurements using the Modification of Diet in Renal Disease equation. CKD was defined as eGFR < 60 mL/min/1.73 m². Cardiac risk (Revised Cardiac Risk Index) and evidence-based, perioperative factors associated with perioperative morbidity (operative time, blood loss, perioperative temperature) were also recorded prospectively. The primary end point was postoperative morbidity, recorded prospectively using the postoperative morbidity survey. Morbidity differences were analyzed between patients with CKD and normal preoperative renal function (χ² test for trend) and presented as hazard ratio (HR) or odds ratio (OR) with 95% confidence intervals (95% CIs). The secondary end points were time to hospital discharge and time to become morbidity free (analyzed by log-rank test), both between and within CKD compared with normal renal function patients. Multiple regression analysis was performed to assess the association of CKD, perioperative factors with morbidity, and length of hospital stay.
RESULTS: Postoperative morbidity survey was recorded in 526 patients undergoing elective orthopedic surgery. CKD patients (n = 142; 27%) sustained excess morbidity on postoperative day 5 (OR 2.1 [95% CI: 1.2-3.7]; P < 0.0001). CKD patients took longer (HR 1.6 [95% CI: 1.2-1.9]) to become morbidity free (log-rank test, P < 0.0001). Time to hospital discharge was delayed by 4 days in CKD patients (HR 1.4 [95% CI: 1.2-1.7]; P = 0.0001; log-rank test). CKD patients sustained more pulmonary (OR 2.2 [95% CI:1.3-3.6]; P = 0.002), infectious (OR 1.7 [95% CI:1.1-2.7]; P = 0.01), cardiovascular (OR 2.4 [95% CI: 1.2-4.8]; P = 0.01), renal (OR 2.3 [95% CI:1.5-3.5]; P < 0.00,001), neurological (OR 4.3 [95% CI:1.3-17.7]; P = 0.005), and pain (OR 1.8 [95% CI:1.03-3.1]; P = 0.04) morbidities. Further stratification of CKD revealed preoperative eGFR ≤ 50 mL/min/1.73 m(2) to be associated with more frequent morbidity and longer hospital stay, independent of age. Multiple regression analysis identified CKD (P = 0.006) and congestive cardiac failure (P = 0.002) as preoperative factors associated with prolonged hospital stay.
CONCLUSIONS: A substantial minority of patients with CKD undergoing elective orthopedic procedures are at increased risk of prolonged morbidity and hospital stay. Preoperative eGFR may enhance perioperative risk stratification beyond traditional risk factors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20807976     DOI: 10.1213/ANE.0b013e3181ee8456

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  36 in total

1.  The Relationship Between Age and Chronic Kidney Disease in Patients Undergoing Pancreatic Resection.

Authors:  Derrick Antoniak; Chandrakanth Are; Chad Vokoun; Kaeli Samson; Lynette Smith; Jason Shiffermiller
Journal:  J Gastrointest Surg       Date:  2018-04-05       Impact factor: 3.452

2.  Renal and Gastrointestinal Considerations in Joint Replacement Surgery.

Authors:  Benjamin Voss; Alexander Kurdi; Alexander Skopec; Jasmine Saleh; Mouhanad M El-Othmani; Joseph M Lane; William M Mihalko; Khaled J Saleh
Journal:  J Nat Sci       Date:  2015-02-01

3.  Thromboprophylaxis with fondaparinux in high-risk postoperative patients with renal insufficiency.

Authors:  Willie Hester; Caitlyn Fry; Daniel Gonzalez; Michael Cohen-Wolkowiez; Brant A Inman; Thomas L Ortel
Journal:  Thromb Res       Date:  2013-11-23       Impact factor: 3.944

4.  Unplanned 30-Day Readmissions after Parathyroidectomy in Patients with Chronic Kidney Disease: A Nationwide Analysis.

Authors:  Rocco Ferrandino; Scott Roof; Yue Ma; Lili Chan; Priti Poojary; Aparna Saha; Kinsuk Chauhan; Steven G Coca; Girish N Nadkarni; Marita S Teng
Journal:  Otolaryngol Head Neck Surg       Date:  2017-09-26       Impact factor: 3.497

5.  Association of preoperative medication with postoperative length of stay in elderly patients undergoing hip fracture surgery.

Authors:  Jianghua Shen; Yahui Yu; Chaodong Wang; Yanqi Chu; Suying Yan
Journal:  Aging Clin Exp Res       Date:  2020-05-21       Impact factor: 3.636

6.  The influence of chronic kidney disease on the duration of hospitalisation and transfusion rate after elective hip and knee arthroplasty.

Authors:  C Kaiser; F P Tillmann; J Löchter; S Landgraeber; M Jäger
Journal:  Int Urol Nephrol       Date:  2018-10-15       Impact factor: 2.370

7.  Which patients are at risk for kidney dysfunction after hip fracture surgery?

Authors:  George A Macheras; Konstantinos Kateros; Stefanos D Koutsostathis; Stamatios A Papadakis; Eleftherios Tsiridis
Journal:  Clin Orthop Relat Res       Date:  2013-12       Impact factor: 4.176

8.  Perioperative management of hysterectomy in a patient with polycystic kidney disease.

Authors:  Savitri K; Ashwini H R; Sreedevi S
Journal:  J Clin Diagn Res       Date:  2014-07-20

Review 9.  Hyperglycemia and Acute Kidney Injury During the Perioperative Period.

Authors:  Carlos E Mendez; Paul J Der Mesropian; Roy O Mathew; Barbara Slawski
Journal:  Curr Diab Rep       Date:  2016-01       Impact factor: 4.810

10.  Moderate to Severe Renal Insufficiency Is Associated With High Mortality After Hip and Knee Replacement.

Authors:  Pyry Jämsä; Esa Jämsen; Heini Huhtala; Antti Eskelinen; Niku Oksala
Journal:  Clin Orthop Relat Res       Date:  2018-06       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.